EGFR and non-small cell lung carcinoma: In a cohort of 84 non-small cell lung cancer patients, the combined use of exosomal-RNA and ctDNA sequencing improved the detection of EGFR (epidermal growth factor receptor)-activating mutations up to 98 vs. 84% for ctDNA alone (Krug et al., 2017).